A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer

Metzenmacher, Martin; Kopp, Hans-Georg; Griesinger, Frank; Reinmuth, Niels; Sebastian, Martin; Serke, Monika; Waller, Cornelius Florian; Thomas, Michael; Eggert, Jochen; Schmid-Bindert, Gerald; Hoiczyk, Mathias; Christoph, Daniel Christian; Kimmich, Martin; Deuss, Burkhard; Seifert, Stephanie; Held, Swantje; Schuler, Martin; Herold, Thomas; Breitenbuecher, Frank; Eberhardt, Wilfried Ernst Erich

A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer

Autor(en):

Metzenmacher, Martin; Kopp, Hans-Georg; Griesinger, Frank; Reinmuth, Niels; Sebastian, Martin; Serke, Monika; Waller, Cornelius Florian; Thomas, Michael; Eggert, Jochen; Schmid-Bindert, Gerald; Hoiczyk, Mathias; Christoph, Daniel Christian; Kimmich, Martin; Deuss, Burkhard; Seifert, Stephanie; Held, Swantje; Schuler, Martin; Herold, Thomas; Breitenbuecher, Frank; Eberhardt, Wilfried Ernst Erich

Tübinger Autor(en):

Kopp, Hans-Georg
Kimmich, Martin

Erschienen in:

Therapeutic Advances in Medical Oncology (2021), Bd. 13, Article 1758835921996506

Verlagsangabe:

Sage Publications Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1177/1758835921996506

ISSN:

1758-8359